There is growing evidence that several lncRNAs are dysregulated in AD or AD-related dementia, and directly or indirectly regulate the key features of AD including Aβ deposition, aberrant tau formation, oxidative stress, neuroinflammation, and neuronal death (Figure 1) [5,6,7,8,9]. The gene discussed is MAPT; the disease is Alzheimer disease.